In summary, this study demonstrates that IGF-1, which is significantly involved in poor prognosis and outcome in women with breast cancer, upregulates Cyr61 through both the MAPK and PI3K/Akt pathways resulting in cell invasion and growth (Figure 6). The gene discussed is AKT1; the disease is breast cancer.